PC Expert
Purdue Pharma L.P. is transitioning to a new public benefit company focused on improving the lives of Americans, supported by a recently filed Chapter 11 Plan of Reorganization. With a commitment to responsible practices, the company is working towards delivering over $7.4 billion in creditor distributions while adhering to ethical compliance and public health initiatives.
Founded on a patient-first approach, Purdue Pharma aims to foster compassionate care and innovation in medicine, as evidenced by its dedication to supporting recovery programs and community health efforts. The company operates with transparency and responsibility, engaging in collaborative research and addressing the ongoing crisis surrounding substance use disorder.
Generated from the website

